OrbiMed key facts
- OrbiMed is a growth equity firm based in New York, New York with 88 tracked portfolio companies.
- Notable positions include InSilico Medicine Cayman (HKG: 03696), Treeline Biosciences, Mirador Therapeutics.
- The team roster lists 87 people.
About OrbiMed
Founded in 1989, OrbiMed is a growth equity firm based in New York. The firm seeks to invest in companies operating in the biopharmaceutical, life sciences, digital health, healthcare services, medical devices, and diagnostic sectors based in Asia, Europe, and North America. This firm is a Registered Investment Adviser (RIA).
OrbiMed portfolio at a glance
88 portfolio companies are on record for OrbiMed, including InSilico Medicine Cayman (HKG: 03696), Treeline Biosciences and Mirador Therapeutics.
49 of the 88 carry a recorded valuation.
OrbiMed team
87 people are on record at OrbiMed: 22 partners, 15 venture partners, 9 managing partners, 9 principals and 32 others. Senior names include Arun Sadhanandham (Managing Director), Carl Gordon (Managing Partner) and Carter Neild (Managing Partner). 87 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 88 recorded positions
- ·Watchlist + alerts for OrbiMed's activity
Portfolio
88 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| InSilico Medicine Cayman (HKG: 03696) | Biotech | ▮ | ▮ | ▮ |
| Treeline Biosciences | — | ▮ | ▮ | ▮ |
| Mirador Therapeutics | — | ▮ | ▮ | ▮ |
+ 85 more companies · all 88, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about OrbiMed
- What companies does OrbiMed invest in?
- OrbiMed has 88 recorded portfolio companies, including InSilico Medicine Cayman (HKG: 03696), Treeline Biosciences, Mirador Therapeutics.
- What is OrbiMed's AUM?
- OrbiMed manages approximately $20.0B in assets.